Development of Peritoneal Tumor-Targeting Vector by In Vivo Screening with a Random Peptide-Displaying Adenovirus Library

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Nishimoto, Takeshi ^a,b   Yamamoto, Yuki ^a   Yoshida, Kimiko ^a   Goto, Naoko ^a   Ohnami, Shumpei ^a   Aoki, Kazunori ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL SURFACE RECEPTOR; POLYPEPTIDE; PROLYLPHENYLALANYLTRYPTOPHYLSERYLGLYCYLALANYLVALINE; UNCLASSIFIED DRUG; VIRUS DNA;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENETIC PROCEDURES; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PERITONEUM METASTASIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RANDOM PEPTIDE DISPLAYING ADENOVIRUS LIBRARY; SCREENING; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL SURFACE DISPLAY TECHNIQUES; FEMALE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PERITONEAL NEOPLASMS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; MIRIDAE;

EID: 84866651410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045550     Document Type: Article

References (27)

1. Volpers C, Kochanek S, (2004) Adenoviral vectors for gene transfer and therapy. J Gene Med 6Suppl 1: S164-171.
2. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.
3. Tomko RP, Xu R, Philipson L, (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94: 3352-3356.
4. Khare R, Chen CY, Weaver EA, Barry MA, (2011) Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 11: 241-258.
5. Yao XL, Nakagawa S, Gao JQ, (2011) Current targeting strategies for adenovirus vectors in cancer gene therapy. Curr Cancer Drug Targets 11: 810-825.
6. Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, et al. (1998) Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 72: 1844-1852.
7. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, et al. (1998) An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72: 9706-9713.
8. Yoshida Y, Sadata A, Zhang W, Saito K, Shinoura N, et al. (1998) Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum Gene Ther 9: 2503-2515.
9. Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, et al. (1999) A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol 17: 470-475.
10. Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, et al. (2001) Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther 4: 534-542.
11. Joung I, Harber G, Gerecke KM, Carroll SL, Collawn JF, et al. (2005) Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector. Biochem Biophys Res Commun 328: 1182-1187.
12. Nicklin SA, White SJ, Nicol CG, Von Seggern DJ, Baker AH, (2004) In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors. J Gene Med 6: 300-308.
13. Muller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, et al. (2003) Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 21: 1040-1046.
14. Miura Y, Yoshida K, Nishimoto T, Hatanaka K, Ohnami S, et al. (2007) Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob. Gene Ther 14: 1448-1460.
15. Nishimoto T, Yoshida K, Miura Y, Kobayashi A, Hara H, et al. (2009) Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob. Gene Ther 16: 669-680.
16. Lupold SE, Kudrolli TA, Chowdhury WH, Wu P, Rodriguez R, (2007) A novel method for generating and screening peptides and libraries displayed on adenovirus fiber. Nucleic Acids Res 35: e138.
17. Yamada H, Yoshida T, Sakamoto H, Terada M, Sugimura T, (1986) Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation. Biochem Biophys Res Commun 140: 167-173.
18. Mittereder N, March KL, Trapnell BC, (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70: 7498-7509.
19. Aoki K, Furuhata S, Hatanaka K, Maeda M, Remy JS, et al. (2001) Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther 8: 508-514.
20. Sagawa T, Takahashi M, Sato T, Sato Y, Lu Y, et al. (2004) Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter. Mol Ther 10: 1043-1050.
21. Mizuguchi H, Koizumi N, Hosono T, Ishii-Watabe A, Uchida E, et al. (2002) CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther 9: 769-776.
22. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
23. Wu P, Kudrolli TA, Chowdhury WH, Liu MM, Rodriguez R, et al. (2010) Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening. Cancer Res 70: 9549-9553.
24. Pesonen S, Kangasniemi L, Hemminki A, (2011) Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data. Mol Pharm 8: 12-28.
25. Eager RM, Nemunaitis J, (2011) Clinical development directions in oncolytic viral therapy. Cancer Gene Ther 18: 305-317.
26. Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R, et al. (2001) Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule. Cancer Res 61: 6377-6381.
27. Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, et al. (2002) Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res 62: 1266-1270.